Evestra has established a network of US and international organizations with experience in hot melt extrusion from academic laboratories to commercial manufacturing. Technology development is based on the extensive experience of our teams of staff members and scientific advisors. The established, and expanding IP portfolio enables the targeted delivery of drugs in a variety of women's healthcare areas such as fertility control, hormone replacement therapy and gynecological indications.